Skip to content

PRTA

Prothena Corporation plc

NASDAQ · IEHealthcareBiotechnology
$8.67+0.12%

Price as of Jul 20, 2026

PRTA capital

Prothena Corporation plc capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.02x
Net debt / equity
-1.03x
Debt / assets
0.02x
Debt / EBITDA
-0.10x
Net debt / EBITDA
4.31x

Liquidity & coverage

Current ratio
10.43x
Quick ratio
10.43x
Cash ratio
10.13x
Interest coverage
EBITDA / interest
Working capital
$306.7M

Cash & dividend

FCF / debt
-10.64x
Cash flow / debt
-10.63x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.